Analysis updated on Nov. 6, 2026 (UTC) · Alpha · vs marketSwitch to Total · Nasdaq
Our AI scores Clover Health Investments, Corp. /De every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
Clover Health Investments, Corp. /De is a mid-cap company with a market capitalization of $2.56B. It ranks number 8 by market capitalization among the 10 Hospital & Medical Service Plans issuers in our coverage with a current forecast. Its P/B Ratio of 6.55x is the highest of the 10 peers that report one. Its D/E Ratio of 0.93x is the lowest of the 10 peers that report one.
For CLOV, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 15.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 27.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +3.1%, buy ≥ +1.5%, sell < -0.5%, strong sell < -1.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-11-06 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, CLOV included.
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Hospital & Medical Service Plans peers listed below that report each metric.
| Metric | CLOV | Rank |
|---|---|---|
| Market Cap | $2.56B | 8/10 |
| P/B Ratio | 6.55x | 1/10 |
| EPS | $-0.09 | – |
| Book Value/Share | $0.74 | – |
| Revenue/Share | $5.16 | – |
| FCF/Share | $0.25 | – |
| Metric | CLOV | Rank |
|---|---|---|
| ROIC | 3.0% | 8/10 |
| Operating Margin | 0.5% | 9/10 |
| EBT Margin | 0.0% | 9/10 |
| Metric | CLOV | Rank |
|---|---|---|
| Current Ratio | 1.55x | 5/10 |
| D/E Ratio | 0.93x | 10/10 |
| Financial Leverage | 1.93x | 10/10 |
| Working Capital | $189M | 8/10 |
| Metric | CLOV | Rank |
|---|---|---|
| Operating Cash Flow | $135M | 8/10 |
| Free Cash Flow | $132M | 7/9 |
| Capital Spending | -$3M | 1/9 |
| FCF/Sales | 4.8% | 4/9 |
| CapEx/Sales | 0.1% | 9/9 |
| Metric | CLOV | Rank |
|---|---|---|
| Asset Turnover | 3.63x | 2/10 |
| Fixed Assets Turnover | 353.4x | 1/10 |
| Metric | CLOV | Rank |
|---|---|---|
| Total Revenue | $2.74B | 9/10 |
| Operating Income | $12M | 10/10 |
| Metric | CLOV | Rank |
|---|---|---|
| Shares Outstanding | 531M | – |
| Total Current Assets | $535M | 71.0% of assets |
| Cash & Short-term Investments | $268M | 35.6% of assets |
| Total Liabilities | $363M | 48.1% of assets |
Companies classified under the same SEC industry code as Clover Health Investments, Corp. /De (Hospital & Medical Service Plans): 10 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| CLOV Clover Health Investments, Corp. /De | $2.56B | |
| UNH Unitedhealth Group Inc | $353.79B | |
| ELV Elevance Health, Inc. | $93.34B | |
| CI Cigna Group | $77.58B | |
| HUM Humana Inc | $52.17B | |
| CNC Centene Corp | $34.53B | |
| MOH Molina Healthcare, Inc. | $11.31B | |
| OSCR Oscar Health, Inc. | $9.46B | |
| TRUP Trupanion, Inc. | $1.61B | |
| ALHC Alignment Healthcare, Inc. | $1.54B |
Hello, and welcome to Clover Health's First Quarter 2026 Earnings Call. [Operator Instructions] Also, as a reminder, this conference is being recorded today. If you have any objections, please ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Reynoso, CEO, Medicare Advantage at Clover Health Investments, Corp. /DE; Transaction: Disposition of 8,750 shares of Class A Common Sto ...
Our AI scores Clover Health Investments, Corp. /De every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
For CLOV, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 15.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 27.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Clover Health Investments, Corp. /De forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Nov. 6, 2026.
10 issuers in our coverage, CLOV included, share the SEC industry code Hospital & Medical Service Plans. The largest are: Unitedhealth Group Inc (UNH), Elevance Health, Inc. (ELV), Cigna Group (CI), Humana Inc (HUM), Centene Corp (CNC), Molina Healthcare, Inc. (MOH).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.
Signals, companies, plans: answered from live data.
I read Intratio's daily model signals, company data and your account to answer in seconds, in your language.
